139 related articles for article (PubMed ID: 29017331)
1. Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer.
Huang ZC; Li H; Sun ZQ; Zheng J; Zhao RK; Chen J; Sun SG; Wu CJ
Neoplasma; 2018; 65(1):161-166. PubMed ID: 29017331
[TBL] [Abstract][Full Text] [Related]
2. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
3. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
[TBL] [Abstract][Full Text] [Related]
4. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
5. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
7. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
Pang Q; Wei Q; Xu T; Yuan X; Lopez Guerra JL; Levy LB; Liu Z; Gomez DR; Zhuang Y; Wang LE; Mohan R; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1332-9. PubMed ID: 23374503
[TBL] [Abstract][Full Text] [Related]
9. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
10. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:
Analysis Based on the Data-mining of Oncomine].
Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
Gao Z; Shi R; Yuan K; Wang Y
Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
[TBL] [Abstract][Full Text] [Related]
12. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Chen J; Chen H; Yang H; Dai H
Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994
[TBL] [Abstract][Full Text] [Related]
13. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.
Lopez Guerra JL; Wei Q; Yuan X; Gomez D; Liu Z; Zhuang Y; Yin M; Li M; Wang LE; Cox JD; Liao Z
Radiother Oncol; 2011 Nov; 101(2):271-7. PubMed ID: 21937138
[TBL] [Abstract][Full Text] [Related]
14. Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer.
Du H; Liu Y; Yuan Y; Zhang Y; Geng H
Ann Clin Lab Sci; 2020 Jul; 50(4):481-489. PubMed ID: 32826245
[TBL] [Abstract][Full Text] [Related]
15. PDE3A is hypermethylated in cisplatin resistant non-small cell lung cancer cells and is a modulator of chemotherapy response.
Tian FM; Zhong CY; Wang XN; Meng Y
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2635-2641. PubMed ID: 28678321
[TBL] [Abstract][Full Text] [Related]
16. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.
Wang J; Hu ZG; Li D; Xu JX; Zeng ZG
Oncol Rep; 2019 Nov; 42(5):1981-1995. PubMed ID: 31545451
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer.
Liu Y; Cui J; Tang YL; Huang L; Zhou CY; Xu JX
Biomed Res Int; 2018; 2018():9815806. PubMed ID: 29607329
[TBL] [Abstract][Full Text] [Related]
19. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
20. Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer.
Wang P; Zhang L; Huang C; Huang P; Zhang J
Med Sci Monit; 2018 May; 24():3578-3590. PubMed ID: 29808834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
